A, et al.Claudin-3 and laudin-4 expression in serous papillary, clear-cell,and endometrioid endometrial cancer. Gynecologic Oncology,2008,109:263-269.
16 Amanda N,Fader CN. Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. Gynecologic Oncology,2009,112:558-562.
17 Fader AN, Drake RD, O Malley DM, et al. Platinum/taxane-based chemotherapy with or without radiotherapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer,2009,115:113-116.
18 Fakiris AJ, Moore DH, Reddy SR,et al. Intraperitoneal radioactive phosphorus (32P)and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01)study.Gynecol Oncol,2005,96:818-823.
19 Villella JA, Cohen S, Smith DH,et al. HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications. Int J Gynecol Cancer,2006,16:1897-1902.
20 Chan S. Targeting the mammalian target of rapamycin (mTOR):a new approach to treating cancer.Br J Cancer,2004,91:1420-1424.
仁和医学论文网专业提供代写代发医学论文服务,并提供大量论文资料,如有业务需求请咨询网站客服人员!
上一页 [1] [2] [3] [4] [5]